Cardiovascular Health and Aromatase Inhibitors

Author： Pritchard Kathleen I.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.66, Iss.13, 2006-01, pp. : 1727-1740

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiovascular Safety Profiles of Aromatase Inhibitors: A Comparative Review

By Nabholtz Jean-Marc  

Drug Safety, Vol. 29, Iss. 9, 2006-01 ,pp. : 785-801

Adis International

Access to resources Recommend Favorite

Aromatase inhibitors

By Grubjesic Simonida   Moriarty Robert M   Pezzuto John M  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 11, 2002-11 ,pp. : 1647-1661

Informa Healthcare

Access to resources Recommend Favorite

Putting the Cardiovascular Safety of Aromatase Inhibitors in Patients with Early Breast Cancer into Perspective: A Systematic Review of the Literature

By Younus Muhammad  

Drug Safety, Vol. 34, Iss. 12, 2011-12 ,pp. : 1125-1149

Adis International

Access to resources Recommend Favorite

Aromatase inhibitors in ovarian stimulation

By Garcia-Velasco Juan A  

Reproductive BioMedicine Online, Vol. 13, Iss. 6, 2006-12 ,pp. : 906-906

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

The therapeutic potential of aromatase inhibitors

By Miller WR   Jackson J  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 3, 2003-03 ,pp. : 337-351

Informa Healthcare

Access to resources Recommend Favorite